These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 18070926

  • 21. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.
    Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP.
    Cancer Res; 2001 Dec 15; 61(24):8917-23. PubMed ID: 11751417
    [Abstract] [Full Text] [Related]

  • 22. Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications.
    Davies SR, Davies ML, Sanders A, Parr C, Torkington J, Jiang WG.
    Int J Oncol; 2010 May 15; 36(5):1129-36. PubMed ID: 20372786
    [Abstract] [Full Text] [Related]

  • 23. WISP-2 as a novel estrogen-responsive gene in human breast cancer cells.
    Inadera H, Hashimoto S, Dong HY, Suzuki T, Nagai S, Yamashita T, Toyoda N, Matsushima K.
    Biochem Biophys Res Commun; 2000 Aug 18; 275(1):108-14. PubMed ID: 10944450
    [Abstract] [Full Text] [Related]

  • 24. Estrogen-induced genes, WISP-2 and pS2, respond divergently to protein kinase pathway.
    Inadera H.
    Biochem Biophys Res Commun; 2003 Sep 19; 309(2):272-8. PubMed ID: 12951045
    [Abstract] [Full Text] [Related]

  • 25. WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways.
    Ji J, Jia S, Jia Y, Ji K, Hargest R, Jiang WG.
    Br J Cancer; 2015 Sep 15; 113(6):921-33. PubMed ID: 26291058
    [Abstract] [Full Text] [Related]

  • 26. CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β.
    Xu H, Li P, Liu M, Liu C, Sun Z, Guo X, Zhang Y.
    Clin Exp Pharmacol Physiol; 2015 Nov 15; 42(11):1207-19. PubMed ID: 26218313
    [Abstract] [Full Text] [Related]

  • 27. WISP-2 is a secreted protein and can be a marker of estrogen exposure in MCF-7 cells.
    Inadera H, Dong HY, Matsushima K.
    Biochem Biophys Res Commun; 2002 Jun 14; 294(3):602-8. PubMed ID: 12056810
    [Abstract] [Full Text] [Related]

  • 28. Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells.
    Itahana Y, Singh J, Sumida T, Coppe JP, Parrinello S, Bennington JL, Desprez PY.
    Cancer Res; 2003 Nov 01; 63(21):7098-105. PubMed ID: 14612502
    [Abstract] [Full Text] [Related]

  • 29. CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen.
    Sarkar S, Ghosh A, Banerjee S, Maity G, Das A, Larson MA, Gupta V, Haque I, Tawfik O, Banerjee SK.
    Oncogenesis; 2017 May 22; 6(5):e340. PubMed ID: 28530705
    [Abstract] [Full Text] [Related]

  • 30. Wnt1 inducible signalling pathway protein-2 (WISP‑2/CCN5): roles and regulation in human cancers (review).
    Ji J, Jia S, Ji K, Jiang WG.
    Oncol Rep; 2014 Feb 22; 31(2):533-9. PubMed ID: 24337439
    [Abstract] [Full Text] [Related]

  • 31. CCN5/WISP-2: A micromanager of breast cancer progression.
    Banerjee SK, Banerjee S.
    J Cell Commun Signal; 2012 Jun 22; 6(2):63-71. PubMed ID: 22487979
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells.
    Belguise K, Guo S, Sonenshein GE.
    Cancer Res; 2007 Jun 15; 67(12):5763-70. PubMed ID: 17575143
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Alteration of ERalpha expression and tumor invasion by RNA interference against metastasis associated-1 gene in human breast cancer cells].
    Jiang QM, Zhang H, Zhang P.
    Zhonghua Bing Li Xue Za Zhi; 2008 Feb 15; 37(2):118-23. PubMed ID: 18681324
    [Abstract] [Full Text] [Related]

  • 37. The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells.
    Mason HR, Lake AC, Wubben JE, Nowak RA, Castellot JJ.
    Mol Hum Reprod; 2004 Mar 15; 10(3):181-7. PubMed ID: 14981145
    [Abstract] [Full Text] [Related]

  • 38. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors.
    Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D, Levine AJ.
    Proc Natl Acad Sci U S A; 1998 Dec 08; 95(25):14717-22. PubMed ID: 9843955
    [Abstract] [Full Text] [Related]

  • 39. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS, Bogart DF, Li P, Mehmi I, Lupu R.
    Oncogene; 2002 Jan 31; 21(6):964-73. PubMed ID: 11840342
    [Abstract] [Full Text] [Related]

  • 40. Loss of WISP2/CCN5 in estrogen-dependent MCF7 human breast cancer cells promotes a stem-like cell phenotype.
    Ferrand N, Gnanapragasam A, Dorothee G, Redeuilh G, Larsen AK, Sabbah M.
    PLoS One; 2014 Jan 31; 9(2):e87878. PubMed ID: 24498388
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.